Patent · US Active

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases

US8969301B2 · kind B2 · utility

9Cited by

44References

10Claims

0Family size

Assignees

aTyr Pharma, Inc. · US
Pangu BioPharma Limited · CN

Inventors

Leslie Ann Greene · San Diego, US
Kyle P. Chiang · Irvine, US
Fei Hong · San Diego, US
Alain P. Vasserot · South San Francisco, US
Wing-Sze Lo · Hong Kong, CN
Jeffry D. Watkins · Encinitas, US
Cheryl L. Quinn · Minneapolis, US
John D. Mendlein · Encinitas, US

Key dates

Filing date	Jul 11, 2011
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Jul 11, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/9015
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.